Home
Live
News
Create
Screeners
Insights
Valiant Laboratories
83.
23
+0.27
(+0.33%)
Market Cap
₹450.60 Cr
PE Ratio
-
Industry
Healthcare
Buy
Sell
Company Performance:
1D
+0.33%
1M
-4.40%
6M
-7.50%
1Y
-20.86%
5Y
-47.36%
View Company Insights
Latest news about Valiant Laboratories
Valiant Laboratories Faces ₹70.81 Lakh GST Show-Cause Notice
Sep 30, 2025
Valiant Laboratories Limited has received a show-cause notice from CGST & Central Excise authorities regarding alleged irregularities in Input Tax Credit (ITC) claims. The notice proposes a disallowance of ₹64.37 lakh in ITC on capital goods for the period April 2021 to March 2022, with a total liability of approximately ₹70.81 lakh including penalties. The company is evaluating the notice and considering appropriate representations to address the matter.
Valiant Laboratories Announces Key Management Changes and Auditor Appointment at AGM
Sep 25, 2025
Valiant Laboratories Reports Robust Q1 Results, Approves Key Management Changes
Aug 08, 2025
Valiant Laboratories Announces Rights Issue: ₹75 Per Share with 1:4 Entitlement Ratio
Jul 15, 2025
Valiant Laboratories Reports Turnaround in Q4 with Improved EBITDA and Revenue
May 20, 2025
Get More Market Insights with
Heatmap
FII/DII
Company Filings
MF Holdings
Bulk/Block Deals
Signals
MTF Insights
F&O Ban - MWPL
Top Deliveries
Market Valuation